To provide another evidence of the effect of combined drugs on HIF-2α function, we examined the effect of each drug and drug combinations on binding of HIF-2α to the putative binding sequence in the Akt promoter using nuclear extracts from AML cells. Here, EPAS1 is linked to acute myeloid leukemia.